While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
This makes the compound a cleaner tool for isolating fat-metabolism effects in experimental research where mitogenic side effects would confound results
Speeds up muscle, tendon & ligament healing Reduces inflammation and chronic pain Strengthens gut lining for better digestion Improves post-surgery and injury recovery Supports healthy blood flow to damaged tissue Helps with nerve repair and mobility May protect against oxidative and toxin-related damage Sports injury recovery Post-surgery healing Tendonitis, ligament tears Chronic joint/muscle pain Gut disorders (GERD, IBS, leaky gut) Lost 40 lbs in 6 months
Bpc-157 Dosing Guidelines Standard dosing ranges from 0.25 to 0.5 mg daily as the therapeutic range for most applications, translating to approximately 1.6 to 4 micrograms per kilogram of body weight
[8] Baca, ibid., lines 15-16
Egypt J Nutr Health